Free Trial

Venus Concept (VERO) Competitors

Venus Concept logo
$0.32 +0.01 (+1.83%)
(As of 12/20/2024 05:31 PM ET)

VERO vs. PXDT, PETV, PAVM, ICU, STRR, TTOO, NURO, BTCY, CUTR, and PSTV

Should you be buying Venus Concept stock or one of its competitors? The main competitors of Venus Concept include Pixie Dust Technologies (PXDT), PetVivo (PETV), PAVmed (PAVM), SeaStar Medical (ICU), Star Equity (STRR), T2 Biosystems (TTOO), NeuroMetrix (NURO), Biotricity (BTCY), Cutera (CUTR), and Plus Therapeutics (PSTV). These companies are all part of the "medical equipment" industry.

Venus Concept vs.

Venus Concept (NASDAQ:VERO) and Pixie Dust Technologies (NASDAQ:PXDT) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, profitability, institutional ownership, media sentiment, community ranking, valuation and earnings.

Venus Concept received 33 more outperform votes than Pixie Dust Technologies when rated by MarketBeat users. However, 100.00% of users gave Pixie Dust Technologies an outperform vote while only 65.38% of users gave Venus Concept an outperform vote.

CompanyUnderperformOutperform
Venus ConceptOutperform Votes
34
65.38%
Underperform Votes
18
34.62%
Pixie Dust TechnologiesOutperform Votes
1
100.00%
Underperform Votes
No Votes

Venus Concept has a beta of 0.58, meaning that its share price is 42% less volatile than the S&P 500. Comparatively, Pixie Dust Technologies has a beta of -0.25, meaning that its share price is 125% less volatile than the S&P 500.

Pixie Dust Technologies has a consensus target price of $5.21, suggesting a potential upside of 798.28%. Given Pixie Dust Technologies' stronger consensus rating and higher possible upside, analysts clearly believe Pixie Dust Technologies is more favorable than Venus Concept.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Venus Concept
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Pixie Dust Technologies
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

87.4% of Venus Concept shares are held by institutional investors. Comparatively, 0.4% of Pixie Dust Technologies shares are held by institutional investors. 58.0% of Venus Concept shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Venus Concept's average media sentiment score of 0.00 equaled Pixie Dust Technologies'average media sentiment score.

Company Overall Sentiment
Venus Concept Neutral
Pixie Dust Technologies Neutral

Pixie Dust Technologies has higher revenue and earnings than Venus Concept.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Venus Concept$67.20M0.03-$37.25M-$8.02-0.04
Pixie Dust Technologies$993.02M0.01-$12.53MN/AN/A

Pixie Dust Technologies has a net margin of 0.00% compared to Venus Concept's net margin of -74.62%.

Company Net Margins Return on Equity Return on Assets
Venus Concept-74.62% N/A -47.46%
Pixie Dust Technologies N/A N/A N/A

Summary

Pixie Dust Technologies beats Venus Concept on 8 of the 13 factors compared between the two stocks.

Get Venus Concept News Delivered to You Automatically

Sign up to receive the latest news and ratings for VERO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VERO vs. The Competition

MetricVenus ConceptSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$2.34M$4.34B$5.13B$9.07B
Dividend YieldN/A44.57%5.08%4.23%
P/E Ratio-0.0425.3789.5817.17
Price / Sales0.0345.951,116.12116.95
Price / CashN/A43.4542.8237.86
Price / Book-0.137.094.774.78
Net Income-$37.25M$13.64M$120.15M$225.60M
7 Day Performance-8.06%-2.93%-1.92%-1.23%
1 Month Performance11.35%0.28%11.47%3.36%
1 Year Performance-68.05%40.76%30.52%16.60%

Venus Concept Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VERO
Venus Concept
1.6226 of 5 stars
$0.32
+1.8%
N/A-65.2%$2.34M$67.20M-0.04410Gap Up
PXDT
Pixie Dust Technologies
1.8586 of 5 stars
$0.58
+9.2%
$5.21
+798.4%
N/A$8.62M$993.02M0.0078High Trading Volume
PETV
PetVivo
N/A$0.42
+1.8%
N/A-47.0%$8.59M$970,000.00-0.8520News Coverage
PAVM
PAVmed
3.7463 of 5 stars
$0.74
-3.2%
$19.00
+2,467.6%
-84.6%$8.19M$2.45M-0.1890News Coverage
ICU
SeaStar Medical
0.1027 of 5 stars
$1.83
-8.0%
N/A-82.0%$8.17M$68,000.00-0.172
STRR
Star Equity
1.0247 of 5 stars
$2.49
-5.3%
N/A-58.5%$8.01M$50.38M-1.02171News Coverage
Gap Up
High Trading Volume
TTOO
T2 Biosystems
2.7832 of 5 stars
$0.38
+3.0%
$5.00
+1,229.8%
-93.4%$7.91M$7.19M0.00180Analyst Forecast
Gap Up
High Trading Volume
NURO
NeuroMetrix
0.7879 of 5 stars
$3.80
-0.3%
N/A+14.2%$7.76M$3.77M-0.8320Gap Down
BTCY
Biotricity
N/A$0.30
-5.1%
N/A-74.1%$7.37M$12.06M-0.2340
CUTR
Cutera
1.1146 of 5 stars
$0.34
-5.1%
$3.00
+780.5%
-85.8%$6.88M$155.21M-0.05430Analyst Forecast
News Coverage
Gap Down
PSTV
Plus Therapeutics
1.5568 of 5 stars
$1.16
-8.7%
$13.50
+1,063.8%
-41.4%$6.84M$4.91M-0.5020

Related Companies and Tools


This page (NASDAQ:VERO) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners